Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.

RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...

We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Maravai LifeSciences (NASDAQ:MRVI) said on Wednesday that based on preliminary year-end results, the company expects to report total 2024 revenue near the mid-point of the previously announced ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...

Maravai LifeSciences Holdings, Inc. announced that it expects total revenue for 2024 to align with its previous guidance range of $255 million to $265 million based on preliminary year-end results ...

TriLink BioTechnologies & Aldveron ink non-exclusive license and supply agreement for CleanCap mRNA capping technology: San Diego, US Thursday, February 6, 2025, 15:00 Hrs [IST] T ...

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...